Wolverine Trading’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,300
Closed -$297K 5387
2023
Q3
$297K Buy
+5,300
New +$298K ﹤0.01% 3308
2023
Q1
Sell
-3,600
Closed -$225K 5119
2022
Q4
$225K Buy
+3,600
New +$239K ﹤0.01% 3030
2022
Q1
Sell
-3,900
Closed -$219K 6689
2021
Q4
$219K Buy
+3,900
New +$238K ﹤0.01% 4579
2020
Q4
Sell
-9,100
Closed -$449K 5625
2020
Q3
$449K Sell
9,100
-3,000
-25% -$125K ﹤0.01% 2938
2020
Q2
$417K Sell
12,100
-4,900
-29% -$169K ﹤0.01% 2941
2020
Q1
$404K Sell
17,000
-3,000
-15% -$89.2K ﹤0.01% 2896
2019
Q4
$543K Buy
+20,000
New +$477K ﹤0.01% 2996

Other funds holding AXNX

Wolverine Trading's AXNX Position: Q2 2022 in Review

Wolverine Trading sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 4,554 shares — an estimated $250K sold.

Wolverine Trading first reported a position in AXNX in Q4 2019 and held it in 4 quarters. The position peaked at $362K in Q4 2019. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

  • Wolverine Trading reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 4,554 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $250K.
  • Wolverine Trading first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Wolverine Trading's Axonics, Inc. Common Stock position peaked at $362K in Q4 2019.
  • 196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.